Back to top

If you wish to go to ZacksFunds.com, click OK. If you do not, click Cancel.

Biotechnology Ultra Sector Pro F: (MF: BIPSX)

(MF) As of Mar 31, 2015 06:05 PM ET

 Add to portfolio

$57.28 USD

-2.01 (-3.39%)

Zacks MF Rank : 1 - Strong Buy [?] 1        

This is our Mutual Fund rating system that serves as a timeliness indicator for Mutual Fund's over the next 6 months:

Zacks Rank Definition
1 Strong Buy
2 Buy
3 Hold
4 Sell
5 Strong Sell

Zacks Mutual Fund Rank FAQ - Learn more about the Zacks Mutual Fund Rank
Zacks Mutual Fund Rank Home - All Zacks Rank resources in one place
Zacks Premium - The only way to get access to the Zacks Rank

General Information as of Feb 28, 2015

% Yield 0.00
% SEC Yield NA
% YTD Return (as of Feb 28, 2015) 9.53
Objective Sector - Health
Peer HL LG

Zacks Premium Research for BIPSX

This is our Mutual Fund rating system that serves as a timeliness indicator for Mutual Fund's over the next 6 months:

Zacks Rank Definition
1 Strong Buy
2 Buy
3 Hold
4 Sell
5 Strong Sell

Zacks Mutual Fund Rank FAQ - Learn more about the Zacks Mutual Fund Rank
Zacks Mutual Fund Rank Home - All Zacks Rank resources in one place
Zacks Premium - The only way to get access to the Zacks Rank

Zacks MF Rank [?] Strong Buy 1
MF Research Report

( = Change in last 30 days)

Zacks Mutual Fund #1 Ranked Funds

View the Zacks Mutual Fund Rank Guide

Portfolio Statistics

%Unrealized Gain YTD 25.06
Net Assets (Mil $) 2/28/2015 19.83
%Turnover 2/28/2015 47.00

Allocation

% of Portfolio
Large Growth 31.65
Large Value 0.00
Small Growth 0.00
Small Value 0.00
Foreign Stock 0.00
Emerging Market 0.00
Precious Metal 0.00
Intermediate Bond 17.92
Foreign Bond 0.00
High Yield Bond 0.00

Sector / Country Weightings

As of 2/28/2015 % of Portfolio
Other 44.35
Health 29.97
Services 16.61
Industrial Cyclical 6.26
Technology 2.81

Portfolio Holdings

Top Equity Holdings
(As of 10/31/2014)
% of Portfolio Value (Mil$)
GILEAD SCIENCES INC 13.96 98.38
AMGEN INC 10.15 71.48
ABBVIE INC 8.33 58.68
CELGENE CORP 7.06 49.77
BIOGEN IDEC INC 6.26 44.10
ALEXION PHARMACEUTICALS I 3.12 22.00
REGENERON PHARMACEUTICALS 2.41 16.98
ILLUMINA INC 2.23 15.69
VERTEX PHARMACEUTICALS IN 2.22 15.65

Stock Holding % of Net Assets

As Of 10/31/2014
Total Issues 29
Avg. P/E 41.45
Avg. P/Book 6.03
Avg. EPS Growth 15.76
Avg. Market Value (Mil $) 93,217

Risk

3 Year 5 Year 10 Year
Beta 1.41 1.28 1.02
Alpha 36.36 20.55 16.98
R Squared 0.29 0.41 0.29
Std. Dev. 24.98 26.39 28.17
Sharpe 2.88 1.78 2.00